Iqvia Holdings Inc.
A health-intelligence giant that helps drugmakers run clinical trials, sell their medicines, and make sense of huge piles of healthcare data—drawing on a trove covering roughly nine in ten of the world's pharmaceuticals. It was born in 2016 when Quintiles, the contract-research firm founded by a statistics professor in 1982, merged with IMS Health, a market-data company from 1954. Its name blends letters from both: the "I" from IMS and "Q" from Quintiles, plus "VIA" for the road ahead.
Granted 575.7K · Sold 124.8K
Granted 52.6K · Bought 4 · Sold 4
Granted 6.3K · Bought 11.3K
Granted 11.8K
Granted 58.8K · Sold 13.1K
Granted 30.6K · Sold 27.3K
Granted 8.3K
Granted 23.6K · Sold 14.1K
Granted 6.3K
Granted 6.3K
Granted 995
Granted 6.7K
Granted 2.7K
Granted 3.6K
Granted 5.4K
Granted 2.4K
Granted 4.0K · Sold 549
Granted 2.1K
Granted 2.1K
Granted 1.1K
Granted 1.0K · Sold 555.1K
Granted 68.0K · Sold 45.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bousbib AriSee Remarks, Director · 33 transactions | +14.3% | 1.41M | 575.7K | — | 124.8K |
| Bruehlman Ronald ESee Remarks · 17 transactions | +70.1% | 56.0K | 52.6K | 4 | 4 |
| Danhakl John GDirector · 8 transactions | — | 31.9K | 6.3K | 11.3K | — |
| Grenfell AlistairSee Remarks · 2 transactions | — | 29.7K | 11.8K | — | — |
| Sherbet EricSee Remarks · 25 transactions | +412.7% | 27.9K | 58.8K | — | 13.1K |
| Panagos ConstantinosSee Remarks · 13 transactions | — | 24.8Kas of Sep 2023 | 30.6K | — | 27.3K |
| Haas BerndSee Remarks · 3 transactions | — | 24.4K | 8.3K | — | — |
| Staub W RichardSee Remarks · 15 transactions | -20.5% | 19.6K | 23.6K | — | 14.1K |
| Leonard John MDirector · 5 transactions | +58.7% | 16.9K | 6.3K | — | — |
| Goggins Colleen ADirector · 5 transactions | +76.6% | 14.5K | 6.3K | — | — |
| Rittenmeyer Ronald ADirector · 2 transactions | +5.5% | 13.5Kas of May 2022 | 995 | — | — |
| Fedock Michael J.See Remarks · 5 transactions | — | 9.5K | 6.7K | — | — |
| Berkshire James G.See Remarks · 2 transactions | — | 8.2K | 2.7K | — | — |
| Burt CarolDirector · 3 transactions | +93% | 7.5K | 3.6K | — | — |
| Patel BhavikSee Remarks · 7 transactions | — | 5.1K | 5.4K | — | — |
| Korakis Emmanuel NSee Remarks · 3 transactions | +28.2% | 4.9Kas of Feb 2022 | 2.4K | — | — |
| Cherofsky KeriannSee Remarks · 15 transactions | — | 3.5K | 4.0K | — | 549 |
| Stamps Sheila ADirector · 2 transactions | — | 2.1Kas of May 2023 | 2.1K | — | — |
| Wims Morris LeslieDirector · 2 transactions | — | 2.1Kas of May 2023 | 2.1K | — | — |
| Fasano JimDirector · 1 transaction | — | 1.1Kas of May 2023 | 1.1K | — | — |
| Connaughton JohnDirector · 4 transactions | — | 1.0Kas of May 2024 | 1.0K | — | 555.1K |
| Knightly Kevin CSee Remarks · 32 transactions | — | 652as of Feb 2024 | 68.0K | — | 45.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -769.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.